Tyra Biosciences, Inc. (TYRA)
33.02
-0.38
(-1.14%)
USD |
NASDAQ |
May 21, 16:00
33.00
-0.02
(-0.06%)
After-Hours: 19:59
Tyra Biosciences Total Assets (Quarterly) : 412.04M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 763.95M |
| Relay Therapeutics, Inc. | 699.61M |
| Tango Therapeutics, Inc. | 435.79M |
| Entrada Therapeutics, Inc. | 335.52M |
| BioMarin Pharmaceutical, Inc. | 8.591B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 24.46M |
| Shareholders Equity (Quarterly) | 387.58M |
| Debt to Equity Ratio | 0.0147 |
| Current Ratio | 20.49 |
| Net Debt Paydown Yield | 0.00% |